Inventor

LIU LONGBIN

CN56 patents

⚠️ This page may combine multiple inventors who share the name “LIU LONGBIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LIU LONGBIN

AMGEN INC

KRAS G12C inhibitors and methods of using the same

Compounds and methods which modulate feeding behavior and related diseases

Compounds and methods which modulate feeding behavior and related diseases

KRAS G12C inhibitors and methods of using the same

Fused heterocyclic derivatives and methods of use

Benzothiazole PI3 kinase modulators for cancer treatment

Imidazopyridazine inhibitors of PI3 kinase for cancer treatment

Substituted heterocycles and methods of use

Substituted piperazines as KRAS G12C inhibitors

KRAS G12C inhibitors and methods of using the same

KRAS G12C inhibitors and methods of using the same

Substituted piperazines as KRAS G12C inhibitors

Substituted pyridines and pyrimidines and their use in treatment of cancer

Integrin inhibitors and their methods of use

Inhibitors of PI3 kinase and/or mTOR

Bis-aryl kinase inhibitors and method

Substituted heterocyclic compounds and methods of use

KRAS G12C inhibitors and methods of using the same

KRAS G12C inhibitors and methods of using the same

Substituted heterocycles and methods of use

Substituted heterocyclic compounds and methods of use

1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use

Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use

Substituted heterocyclic compounds and methods of use

NOVAGEN HOLDING CORP

Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo

Recombinant human interferon-like proteins

Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo

Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo

Polynucleotides encoding human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo

Recombinant human interferon-like proteins and method of treatment using them

Recombinant human interferon-like proteins

Recombinant human interferon-like proteins

Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo

Method of treating diseases with recombinant human interferon-like proteins

Recombinant human interferon-like proteins

CHDI FOUNDATION INC

Compounds and probes for imaging huntingtin protein

Compounds for targeting mutant huntingtin protein and uses thereof

Compounds for targeting mutant huntingtin protein and uses thereof

Heterocyclic compounds and imaging agents for imaging Huntington protein

Heterocyclic compounds and imaging agents for imaging huntingtin protein

HTT modulators for treating Huntington&#39;s disease

WANG HAITAO

Fusion proteins having mutated immunoglobulin hinge region

Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo

Fusion proteins having mutated immunoglobulin hinge region

Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo

Recombinant human interferon-like proteins

KIM TAE-SEONG

Method of treating cancer with substituted amide derivatives

Substituted amide derivatives and methods of use

ALBRECHT BRIAN K

Fused heterocyclic derivatives and methods of use

BO YUNXIN Y

Inhibitors of PI3 kinase

HTT modulators for treating Huntington's disease